TECOGEN INC. current report, 15 May 2014

TECOGEN INC. Form 8-K Summary

Business Context and Reporting Period

This Current Report on Form 8-K was filed by TECOGEN INC. on May 15, 2014, with the earliest event reported on that date. The filing documents the entry into a material definitive agreement for a primary offering of the Company's common stock and the subsequent closing of that offering.

Key Financial Metrics and Transaction Details

The filing details a specific equity financing transaction rather than providing comprehensive financial statements for a reporting period.

  • Offering Price: $4.75 per share.
  • Shares Sold: 647,706 shares of common stock.
  • Total Proceeds: Approximately $3.08 million (calculated as 647,706 shares x $4.75).
  • Placement Agent: Scarsdale Equities LLC.
  • Authorized Offering Size: Up to 2,000,000 shares (commercially reasonable efforts basis).

The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity metrics for the period.

Material Changes and Events

The primary material change reported is the execution of a Placement Agent Agreement on May 15, 2014, and the subsequent execution of Subscription Agreements on May 16, 2014. The offering was officially priced on May 15, 2014, and closed on May 20, 2014.

Guidance, Outlook, and Risks

The filing includes a standard warning concerning forward-looking statements, noting that actual events could differ materially from those indicated due to various risks and uncertainties. The Company explicitly states it does not assume an obligation to update these statements. No specific financial guidance or outlook was provided in the text of this filing.

Key Facts for Investor Verification

  • Verify the final closing date and total shares sold against the May 20, 2014 press release (Exhibit 99.2).
  • Confirm the use of proceeds from the approximately $3.08 million raised.
  • Review the full Placement Agent Agreement (Exhibit 1.1) for any specific terms, fees, or conditions not summarized here.
  • Check subsequent filings for the impact of this dilution on existing shareholders.